ABSTRACT
Introduction
During the management of difficult airway, hypoxemia is a major cause of morbidity and mortality. Maxillofacial trauma represents an especially difficult clinical scenario as the combination of airway bleeding, distorted airway anatomy, uncooperative patient and urgency to secure the airway creates a complex situation with limited options. The American Society of Anesthesiologists (ASA) 2003 Difficult Airway Algorithm uses transtracheal jet ventilation (TTJV) as a near last option. (1) We recently reported the prophylactic use of TTJV during the management of difficult airway in two patients with neck and maxillofacial trauma. (2) Early use of TTJV can provide the anesthesiologist with the additional time necessary to prepare for definitive airway management. This technique should be considered in selective patients who are combative or uncooperative, or who have unusual anatomy, upper airway, facial, and head and neck trauma. Technical details of this procedure can be found in our recent report. (2) Once the jet catheter is placed in the trachea and the oxygen source is attached to the catheter, the patient can be sedated to allow for controlled and less urgent tracheal intubation by the most appropriate technique. In addition to maintaining the patient's oxygenation, TTJV helps the physician in identifying the airway as insufflated oxygen is exiting the glottis creating visible bubbling. In the presence of airway edema, excessive secretions or blood in the airway, this gas escape may help in directing the endotracheal tube during either direct laryngoscopy or fiberoptic bronchoscopy. The objective of this porcine study is to highlight the benefit of oxygenation via prophylactic TTJV. We propose to initiate early TTJV for two reasons: first, to reduce the hypoxemia, and second, to allow more time for definitive airway management either by surgical means or fiberoptic intubation.
Materials and methods
With the approval of our Institutional Animal Care and Use Committee, following guidelines established by the National Institutes of Health for the Care and Use of Laboratory Animals, eighteen pigs (species Sus scrofa) weighing 25 to 30 kg were divided into two groups, Group A and Group B. Pigs in Group A (n = 9), the control group, were induced with pentobarbital, 300 mg, followed by administration of succinylcholine, 60 mg, intravenously (IV). After waiting 90 seconds to simulate a "difficult airway" scenario where ventilation is difficult or impossible, tracheal intubation was performed in less than 30 seconds. In Group B (n = 9), the animals received the same induction as pigs in group A. A 12-gauge catheter (Angiocath ® , Deseret Medical Inc., Park Davis and Company, Sandy, UT) was placed percutaneously across the cricothyroid membrane into the trachea with local anesthesia. Subsequently, Group B pigs received transtracheal ventilation using 100% O 2 at 50 psi at a rate of 15 breaths per minute with an I: E ratio of 1:4 using a manually triggered jet ventilator (Instrumentation Industry, Inc., Bethel Park, PA). Tracheal intubation was performed after waiting 90 seconds. Intubations were achieved in less than 30 seconds. In both groups, arterial blood gases were drawn from pigs before induction and immediately after intubation. Data are expressed as mean + standard deviation. The preintubation and postintubation arterial blood gases were compared using a paired t-test, and the two groups were compared using an unpaired t-test. A value of P < 0.05 was considered significant.
Results
Hypoxemia occurred in Group A (without TTJV) at the end of a 90-second period of apnea (PaO 2 , 22.6 ± 5.8 mm Hg; baseline PaO 2 , 80.5 ± 4.7 mm Hg; P <0.0001, figure 1) . In Group B, oxygenation improved during the 90-second period of TTJV and the time required to intubate (PaO 2 , 470.3 ± 17.0 mmHg; baseline PaO 2 , 83.6 ± 4.2 mm Hg, P <0.0001, figure 1 ). While there was no difference between groups at baseline, the postintubation PaO 2 was significantly higher in pigs receiving TTJV (P <0.0001). In both groups, arterial carbon dioxide tension (PaCO 2 ) increased (Group A: PaCO 2 , 60.5 ± 4.9 mm Hg; baseline PaCO 2 , 41.44 ± 3.71 mm Hg; Group B: PaCO 2 , 44.8 ± 3.9 mm Hg; baseline PaCO 2 , 37.1 ± 1.6 mmHg, figure 2 ). The arterial CO 2 retention in Group A was associated with a mild respiratory acidosis (pH 7.26 ± 0.05).
Discussion
The exact incidence of hypoxemia during the management of difficult airway is not known but is presumed to be high. Mateer et al. studied emergency room endotracheal intubations and reported a 10.4% incidence of hypoxemia. (3) During difficult intubation the incidence of hypoxemia is likely to be even greater.
In our study, we found a large decrease in arterial oxygenation after a 2-minute apnea; this hypoxemia was associated with hypercapnia (61 mmHg) and respiratory acidosis (pH 7.26) (figures 1,2). In contrast, in animals receiving Figure 1 . Control group (nonventilated pigs) became profoundly hypoxemic during apnea. Pigs in TTJV group had improvement in oxygenation during the 2-minute period before tracheal intubation (P values were < 0.0001). Figure 2 . In control and TTJV groups, arterial carbon dioxide tension (PaCO2) increased during the 2-minute period, more so in non-ventilated animals (controls). fiberoptic intubation. Figure 3 depicts a modified maxillofacial trauma algorithm (10) and demonstrates the position within this algorithm we propose for preemptive use of TTJV in scenarios of complex difficult airway. TTJV may be equally helpful in gaining additional time while preparing for other options for invasive airway access (percutaneous tracheostomy and cricothyroidotomy). The use of TTJV is not without complications. One of the most frequently described complications is dislodgement of the catheter during TTJV which may result in subcutaneous emphysema. (11) This potentially catastrophic situation can convert the difficult airway into an "impossible airway." Other complications of TTJV include bleeding, pneumothorax, barotrauma, tracheal and esophageal perforation as well as lifethreatening intravascular misplacement of the catheter. (12) (13) (14) In addition, when TTJV was placed emergently instead of prophylactically, complications were twice as likely to occur. (11) In order to avoid these complications it is of the utmost importance to check the proper position of the catheter before the initiation of jet ventilation by confirming the ability of free-air aspiration with a large syringe. It is equally important to have a dedicated assistant who will keep the catheter secure in the position and who will be monitoring for signs of dislodgement (subcutaneous emphysema).
In conclusion, we have demonstrated in a porcine model that the prophylactic use of TTJV by using a simple, readily available set-up is an efficient method for maintaining arterial oxygenation. This allows extra time for intubation of the trachea either by bronchoscope or direct laryngoscopy during "cannot intubate, cannot ventilate" scenarios or in patients with difficult airway due to head or neck trauma. However, in life-threatening situations where airway access is required, prophylactic TTJV can be placed safely prior to sedation and loss of airway reflexes. When airway is unable to be established, then jet ventilation should be initiated while awaiting surgical intervention. Used with permission from ASA newsletter. (10) TTJV, oxygenation drastically improved while hypercapnia remained at modest level (45 mmHg) during the same time period. Thus, early TTJV prevents hypoxemia and provides the anesthesiologist with extra time to provide sedation, perform tracheal intubation or gain surgical airway. While arrangements for the definitive management of the difficult airway (fiberoptic intubation, surgical airway) may require some preparatory time, a tracheal catheter for jet ventilation can be inserted quickly and atraumatically with readily available equipment such as 12-or 14-gauge angiocatheters. (2) Several studies have evaluated the use of TTJV in animal models. (4-7) Recently, Schaefer et al. demonstrated sufficient oxygenation with TTJV in a porcine model with a self-made airway device similar to the one used in this study. (7) Furthermore, clinical use of TTJV during the management of difficult airway has been reported. (2, 8, 9) We recently reported the usefulness of TTJV placed prophylactically in two patients with neck and maxillofacial trauma. (2) Early use of TTJV allowed us to maintain adequate oxygenation in these uncooperative and critically injured patients and permitted more time for securing the airway with
